Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Endocrine Journal|October 5, 2018
Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevityMiki Okada-Iwabu, Masato Iwabu, Toshimasa Yamauchi, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|January 15, 2014
Adiponectin receptors: a review of their structure, function and how they workToshimasa Yamauchi, Masato Iwabu, Miki Okada-Iwabu, et al.
Diabetology International|October 9, 2019
Drug development research for novel adiponectin receptor-targeted antidiabetic drugs contributing to healthy longevityMiki Okada-Iwabu, Masato Iwabu, Toshimasa Yamauchi, et al.
Clinical Calcium|June 27, 2017
[Aging and homeostasis. Development of novel AdipoR-targeted drugs with exercise-mimicking and anti-aging properties.]Miki Okada-Iwabu, Toshimasa Yamauchi, Masato Iwabu, et al.
International Journal of Molecular Sciences|April 17, 2025
Recent Progress in N-Acylethanolamine Research: Biological Functions and Metabolism Regulated by Two Distinct N-Acyltransferases: cPLA2ε and PLAAT EnzymesToru Uyama, Sumire Sasaki, Miki Okada-Iwabu, et al.
Endocrine Journal|September 13, 2021
Elucidating exercise-induced skeletal muscle signaling pathways and applying relevant findings to preemptive therapy for lifestyle-related diseasesMasato Iwabu, Miki Okada-Iwabu, Takashi Kadowaki, et al.
Frontiers in Cardiovascular Medicine|September 3, 2019
Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related DiseasesMasato Iwabu, Miki Okada-Iwabu, Toshimasa Yamauchi, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Adiponectin/adiponectin receptor in disease and agingMasato Iwabu, Miki Okada-Iwabu, Toshimasa Yamauchi, et al.
Clinical Calcium|March 1, 2016
[Adiponectin receptor-targeted therapy for lifestyle-related diseases]Masato Iwabu, Toshimasa Yamauchi, Miki Okada-Iwabu, et al.
Clinical Calcium|December 28, 2017
[Developing Exercise-mimicking Drugs toward Realization of Preemptive Medicine for Lifestyle-related Diseases.]Masato Iwabu, Toshimasa Yamauchi, Miki Okada-Iwabu, et al.
Pageof 4